Multivessel percutaneous coronary intervention in patients with stable angina: A common approach? Lessons learned from the EHS PCI registry

Heart and Vessels

Volumn 27, Issue 5, 2012, Pages 453-459

  Bauer, Timm ^a,b   Möllmann, Helge ^b   Zeymer, Uwe ^a   Hochadel, Matthias ^a   Nef, Holger ^b   Weidinger, Franz ^c   Zahn, Ralf ^a   Hamm, Christian W ^b   Marco, Jean ^d   Gitt, Anselm K ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b KERCKHOFF HEART CENTER   (Germany)

^c KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^d Centre Cardio Thoracique de Monaco   (Monaco)

Author keywords

Clinical practice; Multivessel disease; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE;

ADULT; AGE; AGED; ARTICLE; BARE METAL STENT; CLINICAL FEATURE; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE REGISTRY; DRUG ELUTING STENT; EUROPE; FEMALE; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGICAL ANATOMY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; STABLE ANGINA PECTORIS; STENT THROMBOSIS; TREATMENT OUTCOME;

AGED; ANGINA, STABLE; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; EUROPE; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REGISTRIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84866731809     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-011-0207-4     Document Type: Article

References (21)

1. Grüntzig A (1978) Transluminal dilatation of coronary-artery stenosis. Lancet 1:263
2. Higashitani M, Mori F, Yamada N, Arashi H, Kojika A, Hoshi H, Minami Y, Yamaguchi J, Yamauchi T, Takagi A, Ogawa H, Hagiwara N (2011) Efficacy of paclitaxel-eluting stent implantation in hemodialysis patients. Heart Vessels. doi:10.1007/s00380-010-0110-4
3. Pepe M, Napodano M, Tarantini G, Fraccaro C, Cutolo A, Peluso D, Isabella G, Ramondo A, Iliceto S (2011) Percutaneous coronary intervention for unprotected left main disease in very high risk patients: safety of drug-eluting stents. Heart Vessels 26:17-24
4. Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB (2003) A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 41:1293-1304
5. Thiele H, Oettel S, Jacobs S, Hambrecht R, Sick P, Gummert JF, Mohr FW, Schuler G, Falk V (2005) Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: a 5-year follow-up. Circulation 112:3445-3450
6. Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, Carrié D, Clayton TC, Danchin N, Flather M, Hamm CW, Hueb WA, Kähler J, Kelsey SF, King SB, Kosinski AS, Lopes N, McDonald KM, Rodriguez A, Serruys P, Sigwart U, Stables RH, Owens DK, Pocock SJ (2009) Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 373:1190-1197
7. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360:961-972
8. Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm CW, Jørgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W (2005) Guidelines for percutaneous coronary interventions. Eur Heart J 26:804-847
9. Onuma Y, Kukreja N, Ramcharitar S, Hochadel M, Gitt A, Serruys P (2009) Interventional treatment in diabetics in the era of drug-eluting stents and compliance to the ESC guidelines: lessons learned from the Euro Heart Survey Programme. Euro-Intervention 4:578-587
10. Ramcharitar S, Hochadel M, Gaster AL, Onuma Y, Gitt A, Serruys PW (2008) An insight into the current use of drug eluting stents in acute and elective percutaneous coronary interventions in Europe. A report on the EuroPCI Survey. EuroIntervention 3:429-441
11. Lenzen MJ, Boersma E, Bertrand ME, Maier W, Moris C, Piscione F, Sechtem U, Stahle E, Widimsky P, de Jaegere P, Scholte op Reimer WJ, Mercado N, Wijns W (2005) Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J 26:1169-1179
12. Goldman LE, Okrainec K, Eisenberg MJ, Schechter D, Lefkovits J, Goudreau E, Deligonul U, Mak KH, Del Core M, Duerr R, Huynh T, Smilovitch M, Sedlis S, Brown DL, Brieger D, ROSETTA Investigators (2004) Six-month outcomes after singleand multi-lesion percutaneous coronary intervention: results from the ROSETTA registry. Can J Cardiol 20:608-612
13. Kornowski R, Mehran R, Satler LF, Pichard AD, Kent KM, Greenberg A, Mintz GS, Hong MK, Leon MB (1999) Procedural results and late clinical outcomes following multivessel coronary stenting. J Am Coll Cardiol 33:420-426
14. Chauhan A, Vu E, Ricci DR, Buller CE, Moscovich MD, Monkman S, Penn IM (1998) Early and intermediate term clinical outcome after multiple coronary stenting. Heart 79:29-33
15. Hernández-Antolin RA, Alfonso F, Goicolea J, Pérez-Vizcayno MJ, Bañuelos C, Fernández-Ortiz A, Escaned J, Azcona L, Rodriguez A, Fernández C, Macaya C (1999) Results ([6 months) of stenting of[1 major coronary artery in multivessel coronary artery disease. Am J Cardiol 84:147-151
16. Laham RJ, Ho KK, Baim DS, Kuntz RE, Cohen DJ, Carrozza JP Jr (1997) Multivessel Palmaz-Schatz stenting: early results and one-year outcome. J Am Coll Cardiol 30:180-185
17. Mathew V, Rihal CS, Berger PB, Bell MR, Garratt KN, Holmes R Jr (1998) Clinical outcome of patients undergoing multivessel coronary stent implantation. Int J Cardiol 64:1-7
18. Orlic D, Bonizzoni E, Stankovic G, Airoldi F, Chieffo A, Corvaja N, Sangiorgi G, Ferraro M, Briguori C, Montorfano M, Carlino M, Colombo A (2004) Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results. J Am Coll Cardiol 43:1154-1160
19. Nienhuis MB, Ottervanger JP, Dambrink JH, Dikkeschei LD, Suryapranata H, van't Hof AW, Hoorntje JC, de Boer MJ, Gosselink AT, Zijlstra F (2007) Troponin T elevation and prognosis after multivessel compared with single-vessel elective percutaneous coronary intervention. Neth Heart J 15:178-183
20. Ijsselmuiden AJ, Ezechiels J, Westendorp IC, Tijssen JG, Kiemeneij F, Slagboom T, van der Wieken R, Tangelder G, Serruys PW, Laarman G (2004) Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison. Am Heart J 148:467-474
21. Shishehbor MH, Topol EJ, Mukherjee D, Hu T, Cohen DJ, Stone GW, McClure R, Roffi M, Moliterno DJ (2006) Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era. Am J Cardiol 97:1585-1590